Tag: Beyfortus
Sanofi: new positive data for Beyfortus – 05/02/2024 at 08:00
(CercleFinance.com) – Sanofi announces that its Beyfortus has reduced the risk of hospitalizations due to respiratory syncytial virus (RSV) by 82% in infants under six months of age, compared to…
Sanofi: encouraging results of Beyfortus against respiratory syncytial virus in infants
(AOF) – Beyfortus reduced the risk of hospitalizations due to respiratory syncytial virus (RSV) by 82% in infants under six months of age, compared to infants who had not been…
Beyfortus treatment confirms its effectiveness in preventing severe cases of bronchiolitis
A mother and her infant in the maternity ward of Dijon University Hospital, September 21, 2023. EMMA BUONCRISTIANI/PHOTOPQR/MAXPPP Two hundred and fifteen thousand infants immunized, and how many hospitalizations avoided?…
Bronchiolitis: Beyfortus helped avoid thousands of hospitalizations in France, according to a study
Europe 1 with AFP: ALINE MORCILLO / HANS LUCAS / HANS LUCAS VIA AFP 2:29 p.m., April 26, 2024 Beyfortus, a treatment intended to limit the risks of bronchiolitis in…
AstraZeneca: approval of Beyfortus in China
(CercleFinance.com) – AstraZeneca announces that Beyfortus (nirsevimab), developed with Sanofi, has been approved in China for the prevention of lower respiratory tract infection (LRTI) by respiratory syncytial virus (RSV) in…
Sanofi: Beyfortus has been approved in China
(CercleFinance.com) – AstraZeneca announces that Beyfortus (nirsevimab), developed with Sanofi, has been approved in China for the prevention of lower respiratory tract infection (LRTI) by respiratory syncytial virus (RSV) in…
Bronchiolitis: 25% additional doses of Beyfortus in the United States, as in France – 12/15/2023 at 6:58 p.m.
The United States, like France, will obtain 25% additional doses of preventive treatment for infants against bronchiolitis compared to their order initially placed for this winter (AFP / John MACDOUGALL)…
the distribution of Beyfortus interrupted in town pharmacies
A doctor prepares to inject a dose of Beyfortus, preventive treatment against bronchiolitis into a 3-day-old infant, in Clamart (Hauts-de-Seine), at the Antoine-Béclère hospital, September 22, 2023. LAURENCE GEAI/MYOP FOR…
Faced with high demand, the new preventive treatment Beyfortus partly restricted to maternity wards
During an epidemic of bronchiolitis, in the pediatric department of Bry-sur-Marne hospital (Val-de-Marne), December 8, 2021. ALINE MORCILLO The Beyfortus treatment, which aims to immunize babies against the main virus…
AstraZeneca: CDC recommendation for Beyfortus
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Sanofi: Beyfortus recommended for infants in the USA
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Sanofi: Beyfortus recommended for infants in the USA
(CercleFinance.com) – Sanofi and AstraZeneca announce that the United States CDC Advisory Committee unanimously recommends Beyfortus (nirsevimab-alip) for the routine immunization of infants against RSV (respiratory syncytial virus) infections. This…